Stephen Komarec is a principal and registered patent attorney at Schwegman, Lundberg and Woessner. He has been practicing in the Twin Cities since 2004. Steve has experience in a variety of mechanical and electro-mechanical related arts including, medical devices, climate control systems, fluid handling systems and aerospace systems. He works with large corporations, small businesses, and independent inventors on issues of patentability, patent infringement, freedom-to-operate, IP due diligence, and strategic counseling. Steve also enjoys working on reissue and design patent applications. During law school, Steve clerked for a judge in United States District Court for the Eastern District of Wisconsin. He has also spent several summers working as an engineering intern at large and small manufacturing companies. Prior to school, Steve served in the United States Army including a deployment to Bosnia during Operation Joint Endeavor. In his free time, Steve enjoys spending time with his wife and three daughters, outdoor activities and following his favorite sports teams.
Oshkosh Corporation has run through a $6.7 billion contract to produce the first 17,000 Joint Light Tactical Vehicles (JLTVs) in a Department of Defense (DOD) program that could produce 55,000 vehicles for the Army and Marines. Oshkosh won the low-rate initial production (LRIP) contract in 2015 to be the sole manufacturer of JLTVs by submitting an original, technologically superior design in a litigated competition with other, arguably, more dominant players in the defense market. Bids for the contract to produce the next tranche of over 15,000 vehicles are due later this year. Competitors for the $7.3 billion recompete contract, including GM Defense, AM General and Navistar, will have access to the proprietary design of the JLTV that Oshkosh used to win the LRIP contract. The U.S. Government has made available to interested bidders a Technical Data Package (TDP) covering the JLTV after purchasing an option in 2016. Oshkosh, however, maintains an intellectual property (IP) portfolio that could counter the sale of the TDP.